Showing 4,861 - 4,880 results of 6,579 for search '(( significant decrease decrease ) OR ( significant ((17 decrease) OR (a decrease)) ))~', query time: 0.50s Refine Results
  1. 4861

    Image 1_Interaction between dietary selenium intake and age on severe headache or migraine in the United States: a population-based study.pdf by Xinping Yu (555177)

    Published 2025
    “…The OR of developing migraine was 0.97 (95% CI: 0.94–0.98) in individuals with selenium intake ≥101.9 ug/day in adults with 20–50 years.</p>Conclusion<p>A higher dietary selenium intake is significantly associated with a decreased prevalence of migraine, and age can modify the association between them. …”
  2. 4862
  3. 4863
  4. 4864
  5. 4865

    Table 2_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.xlsx by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  6. 4866

    Image 1_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.tif by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  7. 4867

    Image 2_Expression, prognosis and preliminary investigation of the mechanism of action of ACTR6, a member of the ARPs gene family, in hepatocellular carcinoma.tif by Jing Wang (6206297)

    Published 2025
    “…</p>Results<p>We found that, in addition to ACTR3C, 17 ARPs were significantly overexpressed in HCC compared with normal tissues. …”
  8. 4868

    Table 1_The effect of omega-3 supplementation on metabolic, inflammatory and oxidative stress biomarkers in pregnant women: a systematic review and meta-analysis.docx by Mohamed J. Saadh (17931488)

    Published 2025
    “…Omega-3 supplementation did not have a significant effect on FBS (SMD = −0.74, 95% CI: −1.94, 0.45), and insulin (SMD = −0.76, 95% CI: −1.77, 0.24), TC (SMD = 0.11, 95% CI: −0.20, 0.42), and LDL-C (SMD = 0.32, 95% CI: −0.17, 0.81), IL-6 (SMD = 2.12, 95% CI: −0.56, 4.80), MDA (SMD = −1.67, 95% CI: −3.39, 0.05), and TAC (SMD = 2.59, 95% CI: −0.37, 5.54). …”
  9. 4869

    Table 1_Blood urea nitrogen-to-albumin ratio as a new prognostic indicator of 1-year all-cause mortality in patients with IPF.docx by Shaobo Ge (20505809)

    Published 2025
    “…The Kaplan–Meier survival curve showed that the 1-year cumulative survival rate of IPF patients with a BAR ≥0.12 was significantly decreased compared with the patients with a BAR <0.12. …”
  10. 4870
  11. 4871

    Table1_Effects of Qingjin Huatan decoction on pulmonary function and inflammatory mediators in acute exacerbations of chronic obstructive pulmonary disease: a systematic review and... by Xuqin Du (8803772)

    Published 2024
    “…Compared to conventional treatment, QHD significantly improved pulmonary function, with increases in FEV1 (MD = 0.30, 95% CI: 0.26 to 0.34, p = 0.000), FVC (MD = 0.34, 95% CI: 0.27 to 0.41, p = 0.000), FEV1/FVC (MD = 6.07, 95% CI: 5.55 to 6.58, p = 0.000), and PaO<sub>2</sub> (MD = 7.20, 95% CI: 4.94 to 9.47, p = 0.000), and a decrease in PaCO<sub>2</sub> (MD = −5.37, 95% CI: 7.99 to −2.74, p = 0.000). …”
  12. 4872
  13. 4873

    Table 1_Effectiveness and safety of hydrogen inhalation therapy as an additional treatment for hypertension in real-world practice: a retrospective, observational study in China.do... by Hongxiang Ji (11235519)

    Published 2024
    “…Both mean SBP and DBP levels significantly decreased in the HI group compared to control group at each follow-up visit with the between group difference of −4.63 mm Hg (95% CI, −6.51 to −2.74) at week 8, −6.69 mm Hg (95% CI, −8.54 to −4.85) at week 16, −7.81 mm Hg (95% CI, −9.57 to −6.04) at week 24 for SBP, and −1.83 mm Hg (95% CI, −3.21 to −0.45) at week 8, −2.57 mm Hg (95% CI, −3.97 to −1.17) at week 16, −2.89 mm Hg (95% CI, −4.24 to −1.54) at week 24 for DBP. …”
  14. 4874
  15. 4875
  16. 4876

    Presentation1_Systematic review of Buzhong Yiqi method in alleviating cancer-related fatigue: a meta-analysis and exploratory network pharmacology approach.PPTX by Ji Zeng (4336561)

    Published 2024
    “…Conversely, PFS, TCM syndrome score, and adverse reaction assessments significantly decreased. The primary active ingredients in its core drugs may exert a positive therapeutic effect on CRF by targeting molecules such as AKT1, IL6, IL1B, PTGS2, CASP3, ESR1, and BCL2, as well as through signaling pathways including TNF, IL17, TLR, NF-κB, and C-type lectin receptor.…”
  17. 4877

    Image 3_The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis.tif by Zechen Zhang (11702123)

    Published 2025
    “…Background<p>Osteoporosis is a metabolic bone disease characterized by decreased bone mass and increased fracture risk. …”
  18. 4878

    Image 1_The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis.tif by Zechen Zhang (11702123)

    Published 2025
    “…Background<p>Osteoporosis is a metabolic bone disease characterized by decreased bone mass and increased fracture risk. …”
  19. 4879

    Table 1_The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis.docx by Zechen Zhang (11702123)

    Published 2025
    “…Background<p>Osteoporosis is a metabolic bone disease characterized by decreased bone mass and increased fracture risk. …”
  20. 4880

    Image 4_The effect of vitamin K2 supplementation on bone turnover biochemical markers in postmenopausal osteoporosis patients: a systematic review and meta-analysis.tif by Zechen Zhang (11702123)

    Published 2025
    “…Background<p>Osteoporosis is a metabolic bone disease characterized by decreased bone mass and increased fracture risk. …”